Merck Outlines Vioxx Defense

January 1, 2005 Comments Off Posted in: General Biotechnology

Merck Outlines Vioxx Defense
At its annual meeting, Merck discussed its planned defense against the flood of lawsuits brought on by the withdrawal of Vioxx, an arthritis pill taken at one time or another by 20 million Americans.

Comments are closed.